Janssen’s RA drug approved in USJanssen Biotech’s rheumatoid arthritis treatment, Simponi Aria (golimumab), has been approved for use in combination with methotrexate in Share XJanssen’s RA drug approved in UShttps://pharmaphorum.com/news/janssen-s-ra-drug-approved-in-us/
Abbott reports healthy Q2 resultsAbbott Laboratories has reported better-than-expected financial results for the second quarter of 2013, with a reported sales increase Share XAbbott reports healthy Q2 resultshttps://pharmaphorum.com/news/abbott-reports-healthy-q2-results/
US FDA grants Alzheimer’s drug fast track statusThe US Food and Drug Administration has granted Fast Track Designation to Transition Therapeutics’ development program for ELNDOO5, Share XUS FDA grants Alzheimer’s drug fast track statushttps://pharmaphorum.com/news/us-fda-grants-alzheimer-s-drug-fast-track-status/
Boehringer and EFSD announce first recipients of €2.5 million diabetes fundingThe recipients of the European-wide funding initiative targeted at diabetes research have been announced today by Boehringer Ingelheim Share XBoehringer and EFSD announce first recipients of €2.5 million diabetes fundinghttps://pharmaphorum.com/news/boehringer-and-efsd-announce-first-recipients-of-2-5-million-diabetes-funding/
Johnson & Johnson announces healthy Q2 resultsJohnson & Johnson has announced sales of $17.9 billion for the second quarter of 2013, which is an Share XJohnson & Johnson announces healthy Q2 resultshttps://pharmaphorum.com/news/johnson-johnson-announce-healthy-q2-results/
Pfizer’s RA drug, tofacitinib, gains approval in several additional countriesPfizer announced yesterday that its rheumatoid arthritis treatment, tofacitinib, has obtained approval for patients with inadequate response to Share XPfizer’s RA drug, tofacitinib, gains approval in several additional countrieshttps://pharmaphorum.com/news/pfizers-ra-drug-tofacitinib-gains-approval-in-several-additional-countries/
Abbott to acquire OptiMedica and enter laser-assisted cataract surgery marketAbbott announced yesterday that it will be acquiring OptiMedica Corporation, a privately held ophthalmic device company. This will Share XAbbott to acquire OptiMedica and enter laser-assisted cataract surgery markethttps://pharmaphorum.com/news/abbott-to-acquire-optimedica-and-enter-laser-assisted-cataract-surgery-market/
AstraZeneca CFO quits to join BG groupSimon Lowth, chief financial officer at AstraZeneca, is going to leave the pharma company at the end of Share XAstraZeneca CFO quits to join BG grouphttps://pharmaphorum.com/news/astrazeneca-cfo-quits-to-join-bg-group/
Conditional EU approval for Roche’s ErivedgeThe European Commission granted conditional approval to Roche’s Erivedge (vismodegib) for the treatment of adult patients with symptomatic Share XConditional EU approval for Roche’s Erivedgehttps://pharmaphorum.com/news/conditional-eu-approval-for-roche-s-erivedge/
